Structural-geometric and functional indicators of the heart in patients with multiple myeloma after anti-tumor treatment and COVID-19
Multiple myeloma is a severe hematologic malignancy characterized by aggressive progression. Over the last decade, the introduction of novel targeted therapies has significantly improved treatment outcomes. Despite these advancements, cardiovascular complications following antitumor therapy continue...
Saved in:
Main Authors: | B. B. Samura, M. O. Panasenko, T. O. Samura, I. V. Chorna |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2025-03-01
|
Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
Subjects: | |
Online Access: | http://pharmed.zsmu.edu.ua/article/view/322559/314596 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
by: B. B. Samura, et al.
Published: (2020-03-01) -
Multiple myeloma and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2020-11-01) -
Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01) -
Prognostic value of P-selectin and sST2 in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-11-01) -
P-selectin and sST2 as prognostic biomarkers of cardiovascular events in patients with multiple myeloma following anticancer therapy and severe COVID-19
by: B. B. Samura, et al.
Published: (2025-07-01)